12 West Capital Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.2M | Hold |
12,521,335
| – | – | 3.19% | 10 |
|
|
2025
Q1 | $27.7M | Buy |
12,521,335
+930,000
| +8% | +$2.06M | 4.08% | 8 |
|
|
2024
Q4 | $63.2M | Sell |
11,591,335
-2,419,844
| -17% | -$13.2M | 6.62% | 5 |
|
|
2024
Q3 | $116M | Buy |
14,011,179
+800,000
| +6% | +$6.65M | 11.91% | 3 |
|
|
2024
Q2 | $94.6M | Buy |
13,211,179
+8,191
| +0.1% | +$58.6K | 9.72% | 6 |
|
|
2024
Q1 | $114M | Buy |
13,202,988
+1,600,000
| +14% | +$13.9M | 10.32% | 3 |
|
|
2023
Q4 | $76M | Buy |
11,602,988
+5,139,877
| +80% | +$33.7M | 6.76% | 5 |
|
|
2023
Q3 | $64.6M | Buy |
6,463,111
+3,101,275
| +92% | +$31M | 5.85% | 7 |
|
|
2023
Q2 | $41.8M | Buy |
3,361,836
+793,066
| +31% | +$9.86M | 3.59% | 14 |
|
|
2023
Q1 | $36M | Buy |
+2,568,770
| New | +$36M | 3.09% | 11 |
|